HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Self-reported treatment practices by healthcare providers could lead to death from Rocky Mountain spotted fever.

Abstract
Among 2012 Docstyle survey respondents, 80% identified doxycycline as the appropriate treatment for Rocky Mountain spotted fever in patients ≥ 8 years old, but only 35% correctly chose doxycycline in patients <8 years old. These findings raise concerns about the higher pediatric case-fatality rate of Rocky Mountain spotted fever observed nationally. Targeted education efforts are needed.
AuthorsJillian Zientek, F Scott Dahlgren, Jennifer H McQuiston, Joanna Regan
JournalThe Journal of pediatrics (J Pediatr) Vol. 164 Issue 2 Pg. 416-8 (Feb 2014) ISSN: 1097-6833 [Electronic] United States
PMID24252781 (Publication Type: Journal Article)
CopyrightCrown Copyright © 2014. Published by Mosby, Inc. All rights reserved.
Chemical References
  • Anti-Bacterial Agents
  • Doxycycline
Topics
  • Adult
  • Aged
  • Anti-Bacterial Agents (adverse effects, therapeutic use)
  • Child
  • Doxycycline (adverse effects, therapeutic use)
  • Female
  • Health Knowledge, Attitudes, Practice
  • Health Personnel (standards)
  • Humans
  • Male
  • Middle Aged
  • Rocky Mountain Spotted Fever (drug therapy, mortality)
  • Self Report
  • Survival Rate (trends)
  • Tennessee (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: